These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15274324

  • 1. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
    Ogawa S, Nagao M, Kanehiro H, Hisanaga M, Ko S, Ikeda N, Nakajima Y.
    Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H.
    Cancer Res; 1998 May 15; 58(10):2057-62. PubMed ID: 9605741
    [Abstract] [Full Text] [Related]

  • 3. Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence.
    Belluco C, Esposito G, Bertorelle R, Alaggio R, Giacomelli L, Bianchi LC, Nitti D, Lise M.
    Eur J Surg Oncol; 2002 Mar 15; 28(2):120-5. PubMed ID: 11884046
    [Abstract] [Full Text] [Related]

  • 4. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N.
    Oncogene; 1999 Apr 01; 18(13):2189-99. PubMed ID: 10327065
    [Abstract] [Full Text] [Related]

  • 5. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]

  • 6. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L, Mosberger I, Grusch M, Rudas M, Chott A.
    J Pathol; 2000 Jan 15; 190(1):20-30. PubMed ID: 10640988
    [Abstract] [Full Text] [Related]

  • 7. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K, Komuta K, Hashimoto S, Matsuzaki S, Kanematsu T, Koji T.
    Clin Cancer Res; 2000 Sep 15; 6(9):3560-4. PubMed ID: 10999744
    [Abstract] [Full Text] [Related]

  • 8. p53 promotes selection for Fas-mediated apoptotic resistance.
    Maecker HL, Koumenis C, Giaccia AJ.
    Cancer Res; 2000 Aug 15; 60(16):4638-44. PubMed ID: 10969818
    [Abstract] [Full Text] [Related]

  • 9. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 15; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 10. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
    Nagao M, Nakajima Y, Hisanaga M, Kayagaki N, Kanehiro H, Aomatsu Y, Ko S, Yagita H, Yamada T, Okumura K, Nakano H.
    Hepatology; 1999 Aug 15; 30(2):413-21. PubMed ID: 10421649
    [Abstract] [Full Text] [Related]

  • 11. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.
    Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, Nishimura R.
    Br J Cancer; 2000 May 15; 82(10):1682-8. PubMed ID: 10817504
    [Abstract] [Full Text] [Related]

  • 12. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
    Younes M, Schwartz MR, Ertan A, Finnie D, Younes A.
    Cancer; 2000 Feb 01; 88(3):524-8. PubMed ID: 10649242
    [Abstract] [Full Text] [Related]

  • 13. Influence of FasL gene expression on hepatic metastasis of colorectal carcinoma.
    Li SY, Yu B, An P, Wei JC, Zuo FY, Cai HY.
    Hepatobiliary Pancreat Dis Int; 2004 May 01; 3(2):226-9. PubMed ID: 15138115
    [Abstract] [Full Text] [Related]

  • 14. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM, Pandeya N, Cummings MC, Walsh MD, Young JP, Leggett BA, Purdie DM, Jass JR, Radford-Smith GL.
    J Pathol; 2003 Sep 01; 201(1):46-54. PubMed ID: 12950016
    [Abstract] [Full Text] [Related]

  • 15. Fas labeling status does not correlate with apoptosis of renal cell carcinoma in vivo.
    Koga F, Arai K, Kamai T, Abe H, Yoshida K.
    Anticancer Res; 2001 Sep 01; 21(5):3193-7. PubMed ID: 11848472
    [Abstract] [Full Text] [Related]

  • 16. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U, Gierschner D, Welchner T, Wetterauer U.
    Anticancer Res; 2003 Sep 01; 23(1A):433-7. PubMed ID: 12680244
    [Abstract] [Full Text] [Related]

  • 17. Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells.
    Schneider-Stock R, Kuester D, Ullrich O, Mittag F, Habold C, Boltze C, Peters B, Krueger S, Hintze C, Meyer F, Hartig R, Roessner A.
    J Pathol; 2006 May 01; 209(1):95-105. PubMed ID: 16575786
    [Abstract] [Full Text] [Related]

  • 18. FasL:Fas ratio--a prognostic factor in breast carcinomas.
    Reimer T, Herrnring C, Koczan D, Richter D, Gerber B, Kabelitz D, Friese K, Thiesen HJ.
    Cancer Res; 2000 Feb 15; 60(4):822-8. PubMed ID: 10706087
    [Abstract] [Full Text] [Related]

  • 19. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
    Korkolopoulou P, Saetta AA, Levidou G, Gigelou F, Lazaris A, Thymara I, Scliri M, Bousboukea K, Michalopoulos NV, Apostolikas N, Konstantinidou A, Tzivras M, Patsouris E.
    Histopathology; 2007 Aug 15; 51(2):150-6. PubMed ID: 17559541
    [Abstract] [Full Text] [Related]

  • 20. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S, Vega M, Garban H, Bonavida B.
    Clin Immunol; 2006 Sep 15; 120(3):297-309. PubMed ID: 16784892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.